Inventor · disambiguated record
Igor Edmondo Paolo D'Angelo
Also filed as: D'ANGELO IGOR · D'ANGELO IGOR EDMONDO PAOLO
11 granted patents·9 pending applications·38 citations·filing 2011–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0191US9388231B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2013·Granted Jul 12, 2016·16 cites·38 claims
- 0290US11306156B2Modified antigen binding polypeptide constructs and uses thereofZYMEWORKS INC·Filed 2015·Granted Apr 19, 2022·7 cites·37 claims
- 0389US10155803B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2016·Granted Dec 18, 2018·3 cites·27 claims
- 0485US2025197527A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS BC INC·Filed 2024·Application pending·0 cites
- 0581US10711051B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2018·Granted Jul 14, 2020·1 cites·21 claims
- 0681US9296815B2Antibodies with enhanced or suppressed effector functionD ANGELO IGOR·Filed 2011·Granted Mar 29, 2016·9 cites·14 claims
- 0778US10358479B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2016·Granted Jul 23, 2019·2 cites·24 claims
- 0871US12286489B2Modified antigen binding polypeptide constructs and uses thereofZYMEWORKS BC INC·Filed 2022·Granted Apr 29, 2025·0 cites·40 claims
- 0969US2021277150A1STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAINZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 1068US11248037B2Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2019·Granted Feb 15, 2022·0 cites·36 claims
- 1168US2021009659A1Multivalent heteromultimer scaffold design and constructsZYMEWORKS INC·Filed 2020·Application pending·0 cites
- 1267US2025215115A1Modified antigen bindingpolypeptide constructs and uses thereofZYMEWORKS BC INC·Filed 2025·Application pending·0 cites
- 1364US10279034B2Anti-PD-L1-anti-TIM-3 bispecific antibodiesLILLY CO ELI·Filed 2018·Granted May 7, 2019·0 cites·14 claims
- 1463US11351251B2Anti-PD-L1-anti-TIM-3 bispecific antibodiesLILLY CO ELI·Filed 2019·Granted Jun 7, 2022·0 cites·7 claims
- 1555US2024209078A1Multitargeting bispecific antigen-binding molecules of increased selectivityAMGEN INC·Filed 2021·Application pending·0 cites
- 1654US2013336973A1Heteromultimer Constructs of Immunoglobulin Heavy Chains with Mutations in the Fc DomainZYMEWORKS INC·Filed 2013·Application pending·0 cites
- 1747US2022403035A1Multitargeting antigen-binding molecules for use in proliferative diseasesAMGEN RES MUNICH GMBH·Filed 2020·Application pending·0 cites
- 1846US11203640B2Checkpoint inhibitor bispecific antibodiesLILLY CO ELI·Filed 2018·Granted Dec 21, 2021·0 cites·5 claims
- 1942US2016159921A1Antibodies with enhanced or suppressed effector functionZYMEWORKS INC·Filed 2016·Application pending·0 cites
- 2042US2014072581A1Immunoglobulin Constructs Comprising Selective Pairing of the Light and Heavy ChainsZYMEWORKS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Igor Edmondo Paolo D'Angelo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →